细胞外基质
肺纤维化
荚体
博莱霉素
纤维化
特发性肺纤维化
成纤维细胞
癌症研究
入侵足纲
肌成纤维细胞
细胞生物学
离体
肺
细胞外
医学
病理
生物
细胞
体外
内科学
癌症
生物化学
细胞骨架
癌细胞
化疗
作者
Ilianna Barbayianni,Paraskevi Kanellopoulou,Dionysiοs Fanidis,Dimitris Nastos,Eleftheria-Dimitra Ntouskou,Apostolos Galaris,Vaggelis Harokopos,Pantelis Hatzis,Eliza Tsitoura,Robert J. Homer,Naftali Kaminski,Katerina M. Antoniou,Bruno Crestani,Argyrios Tzouvelekis,Vassilis Aidinis
标识
DOI:10.1038/s41467-023-41614-x
摘要
Abstract The activation and accumulation of lung fibroblasts resulting in aberrant deposition of extracellular matrix components, is a pathogenic hallmark of Idiopathic Pulmonary Fibrosis, a lethal and incurable disease. In this report, increased expression of TKS5, a scaffold protein essential for the formation of podosomes, was detected in the lung tissue of Idiopathic Pulmonary Fibrosis patients and bleomycin-treated mice. Τhe profibrotic milieu is found to induce TKS5 expression and the formation of prominent podosome rosettes in lung fibroblasts, that are retained ex vivo, culminating in increased extracellular matrix invasion. Tks5 +/- mice are found resistant to bleomycin-induced pulmonary fibrosis, largely attributed to diminished podosome formation in fibroblasts and decreased extracellular matrix invasion. As computationally predicted, inhibition of src kinase is shown to potently attenuate podosome formation in lung fibroblasts and extracellular matrix invasion, and bleomycin-induced pulmonary fibrosis, suggesting pharmacological targeting of podosomes as a very promising therapeutic option in pulmonary fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI